Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Johannes J. M. Kwakman; Erik van Werkhoven; Lieke H. J. Simkens; Johan M. van Rooijen; Yes A. J. van de Wouw; Albert J. ten Tije; Geert-Jan M. Creemers; Mathijs P. Hendriks; Maartje Los; Robbert J. van Alphen; Marco B. Polée; Erik W. Muller; Ankie M. T. van der Velden; Theo van Voorthuizen; Miriam Koopman; Linda Mol; Cornelis J. A. Punt

doi:https://doi.org/10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Johannes J. M. Kwakman, Erik van Werkhoven, Lieke H. J. Simkens, Johan M. van Rooijen, Yes A. J. van de Wouw, Albert J. ten Tije, Geert-Jan M. Creemers, Mathijs P. Hendriks, Maartje Los, Robbert J. van Alphen, Marco B. Polée, Erik W. Muller, Ankie M. T. van der Velden, Theo van Voorthuizen, Miriam Koopman, Linda Mol, Cornelis J. A. Punt

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Citations (Scopus)

Original language	English
Pages (from-to)	e229-e230
Journal	Clinical Colorectal Cancer
Volume	18
Issue number	2
DOIs	https://doi.org/10.1016/j.clcc.2019.01.002
Publication status	Published - 2019

Access to Document

https://doi.org/10.1016/j.clcc.2019.01.002

Cite this

Kwakman, J. J. M., van Werkhoven, E., Simkens, L. H. J., van Rooijen, J. M., van de Wouw, Y. A. J., Tije, A. J. T., Creemers, G.-J. M., Hendriks, M. P., Los, M., van Alphen, R. J., Polée, M. B., Muller, E. W., van der Velden, A. M. T., van Voorthuizen, T., Koopman, M., Mol, L., & Punt, C. J. A. (2019). Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. Clinical Colorectal Cancer, 18(2), e229-e230. https://doi.org/10.1016/j.clcc.2019.01.002

@article{f23a7693210e42c48b334cfed96b5899,

title = "Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group",

author = "Kwakman, {Johannes J. M.} and {van Werkhoven}, Erik and Simkens, {Lieke H. J.} and {van Rooijen}, {Johan M.} and {van de Wouw}, {Yes A. J.} and Tije, {Albert J. ten} and Creemers, {Geert-Jan M.} and Hendriks, {Mathijs P.} and Maartje Los and {van Alphen}, {Robbert J.} and Pol{\'e}e, {Marco B.} and Muller, {Erik W.} and {van der Velden}, {Ankie M. T.} and {van Voorthuizen}, Theo and Miriam Koopman and Linda Mol and Punt, {Cornelis J. A.}",

year = "2019",

doi = "https://doi.org/10.1016/j.clcc.2019.01.002",

language = "English",

volume = "18",

pages = "e229--e230",

journal = "Clinical Colorectal Cancer",

issn = "1533-0028",

publisher = "Elsevier",

number = "2",

}

Kwakman, JJM , van Werkhoven, E, Simkens, LHJ, van Rooijen, JM, van de Wouw, YAJ, Tije, AJT, Creemers, G-JM, Hendriks, MP, Los, M, van Alphen, RJ, Polée, MB, Muller, EW, van der Velden, AMT, van Voorthuizen, T, Koopman, M, Mol, L & Punt, CJA 2019, 'Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group', Clinical Colorectal Cancer, vol. 18, no. 2, pp. e229-e230. https://doi.org/10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. / Kwakman, Johannes J. M.; van Werkhoven, Erik; Simkens, Lieke H. J. et al.
In: Clinical Colorectal Cancer, Vol. 18, No. 2, 2019, p. e229-e230.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

AU - Kwakman, Johannes J. M.

AU - van Werkhoven, Erik

AU - Simkens, Lieke H. J.

AU - van Rooijen, Johan M.

AU - van de Wouw, Yes A. J.

AU - Tije, Albert J. ten

AU - Creemers, Geert-Jan M.

AU - Hendriks, Mathijs P.

AU - Los, Maartje

AU - van Alphen, Robbert J.

AU - Polée, Marco B.

AU - Muller, Erik W.

AU - van der Velden, Ankie M. T.

AU - van Voorthuizen, Theo

AU - Koopman, Miriam

AU - Mol, Linda

AU - Punt, Cornelis J. A.

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066491401&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30782413

U2 - https://doi.org/10.1016/j.clcc.2019.01.002

DO - https://doi.org/10.1016/j.clcc.2019.01.002

M3 - Comment/Letter to the editor

C2 - 30782413

SN - 1533-0028

VL - 18

SP - e229-e230

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

IS - 2

ER -

Kwakman JJM , van Werkhoven E, Simkens LHJ, van Rooijen JM, van de Wouw YAJ, Tije AJT et al. Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group. Clinical Colorectal Cancer. 2019;18(2):e229-e230. doi: https://doi.org/10.1016/j.clcc.2019.01.002

Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group

Access to Document

Other files and links

Cite this